inner-banner-bg

Advances in Hematology and Oncology Research(AHOR)

ISSN: 2692-5516 | DOI: 10.33140/AHOR

Impact Factor: 1.2

Omer Karrar

Omer Karrar, MD
Researcher, Leukemia Department
The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Biography
Dr. Omer Karrar is a dedicated researcher in the field of hematology, focusing on malignant blood disorders. He is currently a research fellow at the University of Texas MD Anderson Cancer Center, where he focuses on clinical outcomes for patients with leukemia. Previously, he worked as a research fellow at the Mayo Clinic, contributing to studies on leukemia therapies, genetic signatures, and treatment outcomes. His research has enhanced the understanding of venetoclax-based therapies, genetic mutations in blood cancers, and treatment-related side effects. Dr. Karrar has authored multiple peer-reviewed publications in leading medical journals. His work aims to advance leukemia treatment and improving patient survival.
Research Interest
AML, ALL, CML, MDS, MPN